FDARecall 99963Medicines
What to do
The FDA record of this recall has no instruction for consumers. Compare the lot codes below with your product. If they match, do not use it, and follow the notice of the firm or ask the store where you bought it. Talk to your pharmacist or doctor before stopping a medicine.Note from Recalls Watch, not agency text.
Read the official notice on accessdata.fda.gov (opens in a new tab)
Hazard
Why it was recalled
Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
FDA classification: Class II. Use may cause temporary or medically reversible health consequences, or the chance of serious consequences is remote. Status: Ongoing.
Is it yours? Products and codes
Type the lot, batch, date code, model number or UPC printed on the product. It is compared here, in your browser, with the codes this notice lists. The code is also added to the page address (?lot=…), so a copied link or result carries it.
General information on recalls from the agency: U.S. Food and Drug Administration (opens in a new tab).
Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10
- Lot or code
- Lot # 24W07, Exp: 11/30/2026
- FDA recall number
- D-0051-2027
- Quantity
- 134 1000-count bottles
Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.
- Lot or code
- Lot # 24W06, Exp: 11/30/2026
- FDA recall number
- D-0052-2027
- Quantity
- 15,815 100-count bottles
Distribution (FDA): US Nationwide and Puerto Rico
About this record
- Issued by
- U.S. Food and Drug Administration
- Firm
- Pfizer (other notices of this firm)
- Title
- Composed by Recalls Watch from fields of the record; FDA records have no title.